296 related articles for article (PubMed ID: 33106549)
1. Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington's disease.
Stan TL; Soylu-Kucharz R; Burleigh S; Prykhodko O; Cao L; Franke N; Sjögren M; Haikal C; Hållenius F; Björkqvist M
Sci Rep; 2020 Oct; 10(1):18270. PubMed ID: 33106549
[TBL] [Abstract][Full Text] [Related]
2. Alteration of Colonic Mucosal Permeability during Antibiotic-Induced Dysbiosis.
Ran Y; Fukui H; Xu X; Wang X; Ebisutani N; Tanaka Y; Maeda A; Makizaki Y; Ohno H; Kondo T; Kono T; Tozawa K; Tomita T; Oshima T; Miwa H
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854266
[TBL] [Abstract][Full Text] [Related]
3. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease.
Kong G; Ellul S; Narayana VK; Kanojia K; Ha HTT; Li S; Renoir T; Cao KL; Hannan AJ
Neurobiol Dis; 2021 Jan; 148():105199. PubMed ID: 33249136
[TBL] [Abstract][Full Text] [Related]
4. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
[TBL] [Abstract][Full Text] [Related]
5. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease.
Kong G; Cao KL; Judd LM; Li S; Renoir T; Hannan AJ
Neurobiol Dis; 2020 Feb; 135():104268. PubMed ID: 30194046
[TBL] [Abstract][Full Text] [Related]
6. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.
Lin R; Zhou L; Zhang J; Wang B
Int J Clin Exp Pathol; 2015; 8(5):5153-60. PubMed ID: 26191211
[TBL] [Abstract][Full Text] [Related]
7. Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals.
Ahmad A; Yang W; Chen G; Shafiq M; Javed S; Ali Zaidi SS; Shahid R; Liu C; Bokhari H
PLoS One; 2019; 14(12):e0226372. PubMed ID: 31891582
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic-Induced Gut Microbiota Dysbiosis Damages the Intestinal Barrier, Increasing Food Allergy in Adult Mice.
Zhang Q; Cheng L; Wang J; Hao M; Che H
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684316
[TBL] [Abstract][Full Text] [Related]
9. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute intra-abdominal hypertension on multiple intestinal barrier functions in rats.
Leng Y; Yi M; Fan J; Bai Y; Ge Q; Yao G
Sci Rep; 2016 Mar; 6():22814. PubMed ID: 26980423
[TBL] [Abstract][Full Text] [Related]
11. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
[TBL] [Abstract][Full Text] [Related]
12. Lifestyle modifications result in alterations in the gut microbiota in obese children.
Cho KY
BMC Microbiol; 2021 Jan; 21(1):10. PubMed ID: 33407104
[TBL] [Abstract][Full Text] [Related]
13. Human Defensin-5 Blocks Ethanol and Colitis-Induced Dysbiosis, Tight Junction Disruption and Inflammation in Mouse Intestine.
Shukla PK; Meena AS; Rao V; Rao RG; Balazs L; Rao R
Sci Rep; 2018 Nov; 8(1):16241. PubMed ID: 30389960
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.
Zhou H; Zhao X; Sun L; Liu Y; Lv Y; Gang X; Wang G
Dis Markers; 2020; 2020():3936247. PubMed ID: 32908614
[TBL] [Abstract][Full Text] [Related]
15. Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis.
Li HL; Lu L; Wang XS; Qin LY; Wang P; Qiu SP; Wu H; Huang F; Zhang BB; Shi HL; Wu XJ
Front Cell Infect Microbiol; 2017; 7():455. PubMed ID: 29124041
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow's milk allergy.
Berni Canani R; De Filippis F; Nocerino R; Paparo L; Di Scala C; Cosenza L; Della Gatta G; Calignano A; De Caro C; Laiola M; Gilbert JA; Ercolini D
Sci Rep; 2018 Aug; 8(1):12500. PubMed ID: 30131575
[TBL] [Abstract][Full Text] [Related]
17. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
Giloteaux L; Goodrich JK; Walters WA; Levine SM; Ley RE; Hanson MR
Microbiome; 2016 Jun; 4(1):30. PubMed ID: 27338587
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the Gut Fungal Community in a Mouse Model of Huntington's Disease.
Kong G; Lê Cao KA; Hannan AJ
Microbiol Spectr; 2022 Apr; 10(2):e0219221. PubMed ID: 35262396
[TBL] [Abstract][Full Text] [Related]
19. Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
Dillon SM; Kibbie J; Lee EJ; Guo K; Santiago ML; Austin GL; Gianella S; Landay AL; Donovan AM; Frank DN; McCARTER MD; Wilson CC
AIDS; 2017 Feb; 31(4):511-521. PubMed ID: 28002063
[TBL] [Abstract][Full Text] [Related]
20. Altered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington's Disease.
Du G; Dong W; Yang Q; Yu X; Ma J; Gu W; Huang Y
Front Immunol; 2020; 11():603594. PubMed ID: 33679692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
